C4 Therapeutics, Inc. (CCCC) total debt

Total debt · fiscal 2025
$59.98M

C4 Therapeutics, Inc. (CCCC) carried total debt of $59.98M at the end of fiscal 2025 (December 31, 2025). That is 8.8% lower than the $65.76M of fiscal 2024. Figures as of 18 Nov 2026, 03:11 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$59.98M
Change on fiscal 2024
−8.8%
Growth, 5 years
+42.9% a year
Highest on record
$87.15Mfiscal 2022
Lowest on record
$10.05Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

C4 Therapeutics, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 42.9% a year. Across the 6 fiscal years on record (2020–2025), the highest was $87.15M in fiscal 2022 and the lowest $10.05M in fiscal 2020.

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

History · 6 fiscal years

Total debt by fiscal year

C4 Therapeutics, Inc. total debt, year by year

C4 Therapeutics, Inc. (CCCC) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$59.98M 8.8% down0.2×
2024$65.76M 7.4% down0.3×
2023$70.98M 18.6% down0.3×
2022$87.15M 709.4% up0.3×
2021$10.77M 7.1% up0.0×
2020$10.05M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on CCCC

C4 Therapeutics, Inc., figure by figure

C4 Therapeutics, Inc. (CCCC) overview: price, valuation and scorecard

C4 Therapeutics, Inc. total debt: questions and answers

How much debt does C4 Therapeutics, Inc. have?

C4 Therapeutics, Inc. (CCCC) carried total debt of $59.98M at the end of fiscal 2025 (December 31, 2025). That is 8.8% lower than the $65.76M of fiscal 2024.

What is the growth rate of C4 Therapeutics, Inc.'s total debt?

Over the five fiscal years to 2025 total debt grew at a compound 42.9% a year.

What are the highest and lowest total debt figures on record for C4 Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $87.15M in fiscal 2022 and the lowest $10.05M in fiscal 2020.

How does C4 Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.2× shareholders' equity at the end of fiscal 2025.

How is C4 Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “C4 Therapeutics, Inc. (CCCC) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/CCCC/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.